Oleuropein is a phenolic compound that can be abundantly found in the olive plant and it possesses pharmacological properties including anticancer, antioxidant, and anti-inflammatory 
INTRODUCTION
Cancer is a rising health concern worldwide with being specifically connected to the massive changes toward an inactive lifestyle and subsequent modification of the environments (Bishayee & Sethi 2016) . Recently, there are great evidences showed the potential role of natural products from various medicinal plants in conferring chemopreventive properties that can interfere tumour carcinogenesis events (Basri et al. 2016; Harun & Ghazali 2012; Neergheen et al. 2010; Zaila et al. 2013) . Chemopreventive phytochemicals may serve as alternative agent to reverse, delay or inhibit tumour initiation, promotion or progression (Neergheen et al. 2010; Salleh et al. 2011) .
Oleuropein that is generally known as one of the most notable phenolic compound in olive plant (Omar 2010 ) has shown to have several pharmacological functions comprising anticancer (Shamshoum et al. 2017) , antioxidant (Barbaro et al. 2014) , anti-inflammatory (Qabaha et al. 2017 ) and antiviral (Micol et al. 2005) . Past studies have demonstrated that oleuropein induced apoptotic activities and suppressed tumour growth in different cancer cells including hepatocellular carcinoma (Yan et al. 2015) and promyelocytic leukemia (Anter et al. 2011) . Though many studies have documented on the anticancer effects of oleuropein on various cancer types, yet the preventive effect of oleuropein specifically at the tumour promotion stage is still undetermined. Therefore, this present study will assess the potential effects of oleuropein on tumour promotion by using a two-stage skin carcinogenesis model.
The two-stage skin carcinogenesis model topically induced by DMBA/TPA on mouse is one of the best in vivo models to be used for tumour development studies in stages involving initiation and promotion stages (Abel et al. 2009; Lindner 2014) . It is said that oxidative stress could contributes to trigger the development of cancer in the initiation and promotion stages (Strzelczyk & Wiczkowski 2012) . Moreover, the oxidative stress is proven to play a pro-neoplastic role in the promotion stage by inhibiting apoptotic activities (Liu et al. 2005 ). Thus, this study aimed to determine whether oleuropein could prevent the promotion stage by using the two-stage skin carcinogenesis model focusing on the analysis of the apoptotic rate and oxidative stress profiles.
MATERIALS AND METHODS

ANIMALS
Seven to eight-week old female ICR mice (n= 24) weighing from 20 g to 30 g were obtained from the Animal Resource Unit, Faculty of Health Sciences, Universiti Kebangsaan Malaysia (UKM). The animals were housed in polypropylene cages at room temperature and 12 h light and dark cycles in the animal house of our faculty with free access to standard mouse pellet diet and fresh tap water ad libitum. Animal welfare and experimental procedures in this study were approved by the animal ethics committee of UKM (approval number: FSK/2016 /FATHIAH/28-SEPT./795-SEPT.-2016 -APR.-2018 .
CHEMICALS AND REAGENTS
Oleuropein, 7,12-dimethylbenz(a)anthracene (DMBA), and 12-O-tetradecanoylphorbol-13-acetate (TPA) were purchased from Sigma-Aldrich, United States.
TWO-STAGE SKIN CARCINOGENESIS MODEL
The dorsal part of the animals was shaved with an electric hair clipper by two days before the beginning of experiment. Total of 24 ICR mice was randomly divided into three groups (n= 8 mice per group) that comprised of two control groups and one treatment group. The first control group received topical application of 200 nmol of DMBA in 100 µL acetone on week one and 20 nmol of TPA in 100 µL acetone for twice per week on week 2 nd until week 10 th ; while the second control group received acetone alone (100 µL). Mice in group 3 received the same treatment of DMBA/TPA as in group 1, and the animals were pretreated with oleuropein, 10 mg/kg body weight (Kimura & Sumiyoshi 2009 ) 30 min before the TPA induction for twice per week until week 10 th .
HISTOPATHOLOGICAL ANALYSIS
All animals were sacrificed one week after the final treatment. The skin tissues on the dorsal part were biopsied and one-half of the tissues was fixated in 10% neutral buffered formalin for 48 h and then transferred to 70% ethanol for tissue processing. Next, processed tissues were embedded in paraffin wax before sectioned to 5 µm thickness and stained with the Haematoxylin and Eosin (H&E) staining. The stained sections were observed under the light microscope for histopathological changes.
ANALYSIS OF APOPTOTIC ACTIVITIES
Immunohistochemistry (IHC) staining on active caspase-3 was performed to determine the apoptotic activity. Tissue sections were deparaffinized in xylene and dehydrated in absolute alcohol. The deparaffinized tissue sections were boiled in commercial citrate buffer for antigen retrieval between 2 and 4 min. Next, to suppress the endogenous peroxidase activity, the tissue sections were treated with 3% hydrogen peroxide solution before treated with blocking serum for 10 min. The sections were incubated with primary antibody of an activated caspase-3 (Cell Signaling Technology) for overnight at 4°C. On the next day, the sections were washed in phosphate buffered saline (PBS) before incubated with secondary horseradish peroxidaseconjugated antibody for 1 h, at room temperature. The brown colour was developed on the sections with DABperoxidase reaction. The sections on slide were mounted and covered with coverslip followed visualization under the light microscope. To determine the rate of apoptotic activities, data was presented as the percentage (%) of number of apoptotic cells expressed as positive labelled cells for active caspase-3 from total of 100 cells in each area under a 20× magnification.
MEASURING OXIDATIVE STRESS AND ANTIOXIDANTS LEVELS
Another half of the biopsied tissues was homogenized using a homogenizer in PBS (0.1M, pH7.4). The homogenized tissue was centrifuged at 3000 rpm for 20 min, at 4°C
temperature to obtain the supernatant. The protein content in the supernatant was assayed using the Lowry method. The estimation of malondialdehyde (MDA) levels that indicates lipid peroxidation together with reduced glutathione (GSH) and superoxide dismutase (SOD) antioxidants levels in each group were analysed in this study. MDA level was assayed according to the reaction of MDA with thiobarbituric acid (TBA) in resulting a pink coloured chromogen of TBA reactive substances (TBARS) and then measured at 532 nm (Stocks & Dormandy 1971) . The level of GSH was determined according to reaction of GSH with 5,5-dithiobis-2-nitrobenzoic acid (DTNB) in resulting a yellow coloured chromogen and then measured at 412 nm (Ellman 1959) . For the level of SOD, it was measured according to reaction of SOD with superoxide in resulting a purple coloured chromogen and then measured at 560 nm (Beyer & Fridovich 1987) .
STATISTICAL ANALYSIS
All data was statistically analysed using the SPSS statistics software version 22. One-way analysis of variance (ANOVA) with Tukey's post hoc test was used to analyse the level of significance between groups. All data was presented in mean and standard error of mean (mean±SEM) with significant values of p<0.05.
RESULTS AND DISCUSSION HISTOPATHOLOGY ANALYSIS
Histopathological changes in the two-stage skin carcinogenesis model on week 10 were demonstrated in Figure 1 (a)-1(c). DMBA/TPA control group displayed thick epidermal hyperplasia together with incoherence arrangement of epithelial cells. In contrast, negative control group showed no changes with a normal single layer of cells. Interestingly, oleuropein pre-treated group depicted mild hyperplasia with a mixture of a normal single epithelial cell, thus indicate a potential effect of oleuropein to prevent the tumour promotion stage. Two-stage skin carcinogenesis model has been used widely to study multi-stage events in the epithelial tumour development from the initiation stage to promotion stage (Masre et al. 2017; Neagu et al. 2016; Rundhaug & Fischer 2010) . Study on the anti-tumour at promotion stage is appraised as the most constructive mode in the field of cancer chemoprevention in regards to reversible factor during the promotion stage compared with the initiation stage which is irreversible (Konoshima & Takasaki 2000) . From our histopathology findings, pre-treatment of oleuropein before TPA-induced promotion stage may have reduced the hyperplastic conditions as indicated with the presence of normal single layer of cells. This is in contrast to the DMBA/TPA control group that appeared with thicker hyperplasia and massive disorganization of epithelial cells. This current data is coincided with previous study on oleuropein treatment that resulted in the reduction of epidermal thickness and tumour incidence on the skin exposed to UVB (Kimura &Sumiyoshi 2009).
ANALYSIS OF APOPTOTIC ACTIVITY
Immunohistochemistry staining that targeted to the active caspase-3 protein was performed on the skin tissues to indicate the status of apoptotic activity (Figure 2 ). Based on the data, oleuropein pre-treated group showed several apoptotic cells that can be seen through activated caspase-3 brown labelling (Figure 2(a)-arrows) . However, there was little to no distribution of apoptotic cells appeared in both DMBA/TPA and negative control groups (Figure 2 (b) and 2(c)). Moreover, the rate of apoptotic activity (%) by activated caspase-3 labelling was also assessed in each group (Figure 3) . From our data, significant increased (p<0.05) of apoptotic rates (%) was displayed in the oleuropein pre-treated group (14.67±0.6%) as compared to the DMBA/TPA group (2.0±0.2%) and negative control group (0.67±0.15%).
To examine the apoptotic activities, IHC analysis of activated caspase-3 that indicates a main executioner apoptosis was conducted in this study. From our data, pre-treatment of oleuropein have displayed the potential to induce pre-cancerous cell death during tumour promotion stage. This is in accordance to the past study that showed induction of apoptosis by oleuropein on hepatocellular carcinoma HepG2 cells and breast cancer MDA-MB-231 cells as mediated via upregulation of activated caspase-3 (Elamin et al. 2013; Yan et al. 2015) . In addition, oleuropein has also been documented to exhibit a specific apoptotic activity on cancer cells than on the normal cells (Elamin et al. 2013 ). Importantly, oleuropein has shown a very high safety profile where it has been given up to 1000 mg/kg to rats and mice with no remarkable evidences of adverse effects (DelBoccio et al. 2003; Kimura & Sumiyoshi 2009 ).
OXIDATIVE STRESS AND ANTIOXIDANTS LEVELS
The levels of lipid peroxidation (MDA) that signify the status of oxidative stress in the oleuropein pre-treated and control groups are shown in Table 1 . MDA levels appeared significantly higher (p<0.05) in the DMBA/TPA control group (4.63±0/41 nmol/mg) compared to oleuropein pre-treated (3.44±0.66 nmol/mg) and negative control (3.17±0.45 nmol/mg) groups. Oxidative stress can involve in the pathogenesis of cancer leading to greater damages on cellular components (Yoshikawa & Naito 2002) . This study indicates that the MDA level has significantly increased owing to oxidative damages that may have occurred following exposure to DMBA/TPA carcinogenic agents. Previous study has shown a significant increase of oxidative DNA damage upon TPA induction on mouse skin (Kim et al. 2007) . It is also said that oxidative stress can trigger tumour promotion by inhibiting apoptotic activities (Liu et al. 2005) . As the MDA level in the oleuropein pretreated group was significantly lower than the DMBA/TPA group, thus, this may reflect the protective potential of oleuropein against the oxidative damage. Moreover, the significance increased of the MDA level may be linked to the low apoptotic rates (%) in the DMBA/TPA group ( Figure  2(b) ). The level of GSH that acts as a key role in the nonenzymatic antioxidant defence system was measured in this study (Table 1) . According to the data, DMBA/TPA control group showed the highest level of GSH (2.87×10-3±3.11×10-4 nmol/mg) whilst low level of GSH displayed in the negative control (2.35×10-3±1.01×10-4 nmol/mg) and oleuropein pre-treated (1.76×10-3±1.86 ×10-4 nmol/ mg) groups. Statistical analysis showed a significant difference (p<0.05) in the GSH levels between DMBA/ TPA and treatment groups. In addition, the level of SOD that plays a role in the enzymatic antioxidant defence system was also measured in this study (Table 1) . SOD levels appeared highly in the oleuropein pre-treated group (0.73±0.05 µ/mg), followed by negative control (0.63±0.03 µ/mg) and DMBA/TPA control groups (0.57±0.24 µ/mg). Statistical analysis showed a significant difference (p<0.05) in the SOD levels between oleuropein pre-treated and DMBA/ TPA control groups.
For the antioxidants status, the measurement of GSH and SOD levels was performed in this study. Both GSH and SOD play an important role as protective antioxidants during oxidative damage (Ighodaro & Akinloye 2017; Thorsen 2012 ). Interestingly, the GSH level was FIGURE 3. The rate of apoptotic activity (%) in oleuropein pre-treated, DMBA/TPA and negative control groups. Oleuropein pre-treated group showed a significant increase (p<0.05) of the apoptotic rates (%) compared with DMBA/TPA* and negative control** groups significantly lower (p<0.05) in the oleuropein pre-treated group compared to DMBA/TPA group. It has been shown that the activation of apoptosis by anticancer agents was triggered by the downregulation of GSH levels (Friesen et al. 2004 ). Thus, the significant low level of GSH (p<0.05) in the oleuropein pre-treated group is responsible to the significant increase (p<0.05) of apoptotic rates upon treatment with oleuropein in this study. Moreover, as it is proven that oxidative stress is elevated during the initiation and promotion stages (Strzelczyk & Wiczkowski 2012) , thus, the presence of free radicals during carcinogenesis may possibly influence the level of GSH (Lagman et al. 2015) leading to its depletion as shown in our finding. For the SOD levels, significantly increased (p<0.05) in the oleuropein pre-treated group was shown in this study. This finding is in line to the previous study that depicted significant elevation of SOD levels upon treatment with oleuropein leading to growth inhibition of breast cancer (Milanizadeh et al. 2014) . With that, present study indicates that oleuropein induced the SOD level while causing reduction of GSH level during tumour promotion stage. The likely explanation could be that the potential suppressive effects of oleuropein on free radicals' production from oxidative damage could be mediated through its differential effects in targeting the antioxidants. However, further investigations are required to clarify that.
CONCLUSION
In conclusion, pre-treatment of oleuropein in the tumour promotion stage have shown the ability to reduce the thickness in epidermal hyperplasia and significantly promote apoptotic activities. Moreover, pre-treatment of oleuropein showed significant low level of MDA indicating a potential role of oleuropein to protect the epithelial cells from oxidative damage at the promotion stage. This possible protective sign has been further demonstrated through the antioxidants GSH and SOD levels in this study. Overall, oleuropein has potential effects to increase apoptotic rates, act as a protective antioxidant and reduce oxidative stress. Therefore, oleuropein could be further investigated and developed as a chemopreventive agent in skin carcinogenesis or other epithelial cancers via its apoptotic and antioxidant activities on tumour promotion. 
